The Gamaleya Center has developed a rabies vaccine called GamRabiVac. The new drug is administered once, which distinguishes it from traditional inactivated rabies vaccines. According to the Union of Doctors, this is an adenoviral vector-based vaccine, like Sputnik V COVID-19 vaccine. According to the publication, the first stage of the research was estimated at 4.4 million rubles.
The development of the vaccine and its trials...
На этом веб-сайте используются cookie — файлы для обеспечения быстрой работы сайта и оценки его использования через сервисы веб-аналитики. Если Вы согласны с использованием cookie-файлов, нажмите «Соглашаюсь». Подробнее об использовании cookies можно узнать в Политике конфиденциальности.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
